CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 124,458	$ 81,808
Restricted cash	3,750	1,549
Patient accounts receivable	274,570	255,145
Prepaid expenses	16,080	10,217
Other current assets	14,024	13,265
Total current assets	432,882	361,984
Property and equipment, net of accumulated depreciation of $100,407 and $95,024	20,381	23,719
Operating lease right of use assets	100,028	93,440
Goodwill	1,188,054	932,685
Intangible assets, net of accumulated amortization of $20,309 and $22,973	118,084	74,183
Deferred income taxes	10,111	47,987
Other assets	68,105	33,200
Total assets	1,937,645	1,567,198
Current liabilities:
Accounts payable	41,649	42,674
Payroll and employee benefits	155,123	146,929
Accrued expenses	154,264	166,192
Provider relief fund advance	58,535	60,000
Current portion of long-term obligations	13,225	10,496
Current portion of operating lease liabilities	31,553	30,046
Total current liabilities	454,349	456,337
Long-term obligations, less current portion	434,781	204,511
Operating lease liabilities, less current portion	67,723	61,987
Other long-term obligations	31,991	33,622
Total liabilities	988,844	756,457
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,659,284 and 37,470,212 shares issued; and 32,590,775 and 32,814,278 shares outstanding	38	38
Additional paid-in capital	720,875	698,287
Treasury stock, at cost 5,068,509 and 4,655,934 shares of common stock	(420,665)	(319,092)
Retained earnings	605,016	429,991
Total Amedisys, Inc. stockholders’ equity	905,264	809,224
Noncontrolling interests	43,537	1,517
Total equity	948,801	810,741
Total liabilities and equity	$ 1,937,645	$ 1,567,198